New drug shows promise in reversing dangerous liver scarring
Disease control
Completed
This study tested whether a weekly injection called pemvidutide could help people with a serious fatty liver disease called NASH. Researchers compared the drug to a placebo in 212 adults to see if it could reduce liver inflammation and scarring. The main goal was to see if the dr…
Phase: PHASE2 • Sponsor: Altimmune, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC